Evidence map›Paper›PMID 32215177›Full record

ArticleOxidative medicine and cellular longevity2020

Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia.

Liren Zhong, Wei Ding, Qingyu Zeng, Binglin He, Haibo Zhang, Li Wang, Junhong Fan, Shuhua He, Yuanyuan Zhang, Anyang Wei

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Liren ZhongDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Wei DingDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Qingyu ZengDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Binglin HeDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Haibo ZhangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Li WangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Junhong FanDepartment of Urology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Shuhua HeDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Yuanyuan ZhangWake Forest Institute of Regenerative Medicine University, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.ORCID https://orcid.org/0000-0002-5708-9718
Anyang WeiDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0001-7585-8210
Nanfang Hospital · CNAffiliated Hospital of Guizhou Medical University · CNForest Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperlipidemia is considered one of the most important risk factors for erectile dysfunction (ED). To determine the effect of sodium tanshinone IIA sulfonate (STS) as an antioxidant agent on ED in high-fat diet- (HFD-) induced hyperlipidemia in rats and to investigate if STS administration could improve erectile function via hydrogen sulfide (H

Indexed as

AnimalsAntioxidantsCells, CulturedDiet, High-FatErectile DysfunctionHydrogen PeroxideHydrogen SulfideHyperlipidemiasInjections, IntraperitonealMaleOxidation-ReductionOxidative StressPenisPhenanthrenesRatsRats, Sprague-DawleyAntioxidantsHydrogen PeroxideHydrogen SulfidePhenanthrenestanshinone II A sodium sulfonate

Identifiers

PMID32215177
PMCPMC7081035
OpenAlexW3010507277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.